Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010
Abstract:A baseline serotype distribution was established by age and region for 2058 invasive
Document Type: Research Article
Affiliations: 1: National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB R3E 3R2, Canada. 2: Laboratoire de santé publique du Québec, 20045 chemin Sainte-Marie, Ste-Anne-de-Bellevue, QC H9X 3R5, Canada. 3: Toronto Invasive Bacterial Diseases Network, Department of Microbiology, Mount Sinai Hospital, 600 University Avenue, Room 210, Toronto, ON M5G 1X5, Canada. 4: Vaccine Preventable Diseases Section, Surveillance and Outbreak Response Division, Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada, Room 273A, 2nd Floor, 130 Colonnade Road, AL 6502A, Ottawa, ON K1A 0K9, Canada. 5: Department of Medical Microbiology and Infectious Diseases, Faculty of Medicine, University of Manitoba, Winnipeg, MB R3T 2N2, Canada. 6: Provincial Laboratory for Public Health (Microbiology), Walter Mackenzie Health Sciences Centre, 8440 - 112 Street, Edmonton, AB T6G 2J2, Canada.
Publication date: August 24, 2012
- Published since 1954, this monthly journal contains new research in the field of microbiology including applied microbiology and biotechnology; microbial structure and function; fungi and other eucaryotic protists; infection and immunity; microbial ecology; physiology, metabolism and enzymology; and virology, genetics, and molecular biology. It also publishes review articles and notes on an occasional basis, contributed by recognized scientists worldwide.
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Terms & Conditions
- Sample Issue
- Reprints & Permissions
- ingentaconnect is not responsible for the content or availability of external websites